Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT-002-158 in Chinese Adult Patients With Hidradenitis Suppurativa
NCT06932003Phase 2Recruiting
- Sponsor
- Leadingtac
- Start
- Jul 2025
- Primary completion
- Oct 2028
- Modality
- Bivalent/Multivalent Binders, PROTACs (E3 ligase recruitment)
- Countries
- 1
01
Overview
A Phase 2 trial of LT-002 in hidradenitis suppurativa (HS), sponsored by Leadingtac. Started Jul 2025; status: recruiting.
02
Drugs
LT-002
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT06932003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06932003.